Travel burden associated with rare cancers: The example of Merkel cell carcinoma
Abstract Background There are limited data on the travel burden for cancer patients with rare tumor types, such as Merkel cell carcinoma (MCC). Objective The objective of this study was to understand the travel burden of MCC patients. Methods This study used data from an MCC registry at the Seattle...
Main Authors: | Rahul Jain, Joseph Menzin, Kristina Lachance, Patrick McBee, Hemant Phatak, Paul T. Nghiem |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2085 |
Similar Items
-
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
by: Shailender Bhatia, et al.
Published: (2022-08-01) -
Defining the Profile of Patients with Primary Merkel Cell Carcinoma in Central Italy: A Retrospective Analysis
by: Giulio Gualdi, et al.
Published: (2022-10-01) -
Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
by: Bharmal M, et al.
Published: (2019-05-01) -
Insights into anti-tumor immunity via the polyomavirus shared across human Merkel cell carcinomas
by: Saumya Jani, et al.
Published: (2023-05-01) -
Merkel Cell Polyomavirus and Merkel Cell Carcinoma
by: Valeria Pietropaolo, et al.
Published: (2020-07-01)